Patents by Inventor Kouichi Kamogawa

Kouichi Kamogawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
    Patent number: 5766594
    Abstract: Antigen proteins of Mycoplasma gallisepticum, genes encoding the antigen protein, recombinant vectors integrated with the gene and hosts transformed with the vector are provided. Diagnostics and vaccine using the antigen protein produced by such hosts are effective for poultry, especially chicken infected with Mycoplasma gallisepticum. Vaccination can maintain poultry free of Mycoplasma gallisepticum infection.
    Type: Grant
    Filed: January 2, 1997
    Date of Patent: June 16, 1998
    Assignees: Nippon Zeon Co., Ltd., Shionogi & Co., Ltd.
    Inventors: Kazumi Kodama, Shuji Saito, Noboru Yanagida, Kouichi Kamogawa, Yoshikazu Iritani, Shigemi Aoyama
  • Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
    Patent number: 5621076
    Abstract: Antigen proteins of Mycoplasma gallisepticum, genes encoding the antigen protein, recombinant vectors integrated with the gene and hosts transformed with the vector are provided. Diagnostics and vaccine using the antigen protein produced by such hosts are effective for poultry, especially chicken infected with Mycoplasma gallisepticum. Vaccination can maintain poultry free of Mycoplasma gallisepticum infection.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: April 15, 1997
    Assignees: Nippon Zeon Co., Ltd., Shionogi & Co., Ltd.
    Inventors: Kazumi Kodama, Shuji Saito, Noboru Yanagida, Kouichi Kamogawa, Yoshikazu Iritani, Shigemi Aoyama
  • Recombinant avipoxvirus
    Patent number: 5387519
    Abstract: A recombinant Avipoxvirus having inserted exogenous DNA in a DNA region non-essential to proliferation of Avipoxvirus is provided. The recombinant Avipoxvirus is produced by inserting a promoter and exogenous DNA capable of expression under its control into a DNA region non-essential to proliferation of Avipoxvirus, utilizing DNA coding for a readily detectable enzyme, or, non-homologous DNA fragment.
    Type: Grant
    Filed: September 3, 1991
    Date of Patent: February 7, 1995
    Assignee: Nippon Zeon Co., Ltd.
    Inventors: Noboru Yanagida, Sakiko Saeki, Ryohei Ogawa, Kouichi Kamogawa
  • Recombinant avipoxvirus
    Patent number: 5286639
    Abstract: A recombinant Avipoxvirus having inserted all or a part of cDNA coding for Newcastle disease virus-derived hemagglutinin neuraminidase in a genome region non-essential to proliferation of Avipoxvirus is provided. The recombinant Avipoxvirus is utilizable as vaccine for fowl.
    Type: Grant
    Filed: February 8, 1991
    Date of Patent: February 15, 1994
    Assignee: Nippon Zeon Co., Ltd.
    Inventors: Noboru Yanagida, Sakiko Saeki, Ryohei Ogawa, Kouichi Kamogawa, Yoshiyuki Hayashi, Kazunari Sawaguchi